Qms Medical Allied Services Ltd (QMSMEDI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Qms Medical Allied Services Ltd on NSE and BSE, with an AI summary of each filing.
QMS Medical Allied Services Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 02 Oct 2026, 8:59 pm
QMS Medical Allied Services Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Annual General Meeting · 01 Oct 2026, 6:08 pm
QMS Medical Allied Services Limited has informed the Exchange regarding a press release dated September 28, 2026, titled "QMS Medical Allied Services to acquire Beamoptics Scientific a Pune-based diagnostics and Analytical deep-tech company".
Press Release · 28 Sept 2026, 4:52 pm
QMS Medical Allied Services to Acquire 100% Equity in Beamoptics Scientific QMS Medical Allied Services signed an MoU on 28th Sep'26 to acquire 100% equity in Pune-based deep-tech manufacturer BeamOptics Scientific, expanding its presence in IVD devices and analytical instruments. The transaction will close post-NCLT approval of a composite scheme of arrangement with Health Care at Home (HCAH). Concurrently, QMS is demerging its services and patient services portfolio into subsidiary Saarathi Healthcare to create a separate listed services entity, retaining focus on its core product business alongside an exclusive five-year Indian distribution deal signed with Germany's HEINE Optotechnik in Aug'26.
QMS Medical Allied Services Limited has informed the Exchange regarding a press release dated September 25, 2026, titled "HCAH and QMS Join Hands to Create India s Largest Patient Support Program Platform".
Press Release · 26 Sept 2026, 1:08 am
QMS and HCAH Merge Pharma Services into Saarathi Healthcare On 25th Sep'26, QMS Medical Allied Services and Health Care At Home India signed definitive agreements to merge their Patient Support Program (PSP) business verticals into Saarathi Healthcare, a 100% subsidiary of QMS. The combined entity creates India's largest PSP platform, operating 160+ programs covering over 1.2 million patients across 35+ cities with 2,000+ professionals. The transaction targets India's domestic PSP market, which is projected to grow at a 15–20% CAGR to approximately US$1 billion by 2030, enhancing execution reach for pharmaceutical clients.
QMS Medical Allied Services Limited has informed the Exchange about Acquisition
Others (Uncategorized) · 26 Sept 2026, 12:28 am
QMS Medical Allied Approves Healthcare Services Demerger and BeamOptics Acquisition QMS Medical Allied Services approved a composite Scheme of Arrangement on 25th Sep'26 to demerge the Healthcare Services businesses of QMS and Health Care at Home India into Saarathi Healthcare, which will seek listing on the NSE. QMS shareholders will receive 1 share in Saarathi for every 1 share held. The demerged division generated Rs 37.17 cr revenue (24.41% of FY26 total). Separately, QMS executed a binding MOU to acquire 100% of BeamOptics Scientific by 30th Nov'27 at an independently assessed valuation.
QMS Medical Allied Services Limited has informed the Exchange about Agreements
Others (Uncategorized) · 26 Sept 2026, 12:19 am
QMS Medical Approves Demerger Scheme, Listing Plan, and BeamOptics Acquisition QMS Medical Allied Services approved a composite scheme of arrangement to demerge its Healthcare Services Business (turnover of Rs 37.17 cr; 24.41% of total FY26 revenue) and that of Health Care at Home India into Saarathi Healthcare, which will seek listing on NSE. Eligible QMS shareholders will receive 1 share in Saarathi for every 1 share held. Concurrently, QMS entered a binding MOU to acquire a 100% stake in BeamOptics Scientific by 30th Nov'27 at an independent valuer-determined price.
QMS Medical Allied Services Limited has informed the Exchange about Memorandum of Understanding/Agreements
Others (Uncategorized) · 26 Sept 2026, 12:17 am
QMS Medical Approves Healthcare Services Demerger and BeamOptics Acquisition QMS Medical Allied Services approved a composite scheme to demerge its Healthcare Services Business (FY26 revenue: Rs. 37.17 Cr, 24.41% of total turnover) alongside Health Care at Home India into Saarathi Healthcare, which will seek listing on the NSE. QMS shareholders will receive 1 Saarathi equity share for every 1 share held. Simultaneously, QMS executed an MOU to acquire 100% of BeamOptics Scientific (FY26 turnover: Rs. 113.81 Lakhs) at a valuer-determined consideration, target completion by 30th Nov'27.
QMS Medical Allied Services Limited has informed the Exchange about Scheme of Arrangement
Others (Uncategorized) · 26 Sept 2026, 12:16 am
QMS Medical Approves Healthcare Demerger into Saarathi and 100% BeamOptics Acquisition QMS Medical Allied Services approved a composite scheme on 25th Sep'26 to demerge its Healthcare Services Business—representing Rs 37.17 crore or 24.41% of FY26 turnover—alongside Health Care At Home India's division into Saarathi Healthcare, which will seek an NSE listing. QMS shareholders will receive 1 equity share in Saarathi for every 1 share held. Additionally, QMS executed a binding MOU to acquire 100% of BeamOptics Scientific for an independent-valuation-based consideration, targeted for completion by 30th Nov'27.
QMS Medical Allied Services Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026.
Outcome · 26 Sept 2026, 12:14 am
QMS Medical Allied Approves Healthcare Demerger Scheme and BeamOptics Acquisition QMS Medical Allied Services approved a composite demerger scheme on 25th Sep'26 to transfer its healthcare services business—generating ₹37.17 crore turnover (24.41% of total) in FY26—alongside Health Care at Home India’s business into Saarathi Healthcare, which will seek listing on the NSE. QMS shareholders receive 1 Saarathi equity share per 1 share held. Post-scheme, public holding in Saarathi stands at 59.5%. Additionally, QMS executed a binding MoU to acquire 100% of BeamOptics Scientific by 30th Nov'27 at an independent valuation.
QMS Medical Allied Services Limited has informed the Exchange regarding a press release dated September 18, 2026, titled "QMS Medical Allied Services Completes 100% Acquisition of Saarathi Healthcare Pvt Ltd.".
Press Release · 18 Sept 2026, 4:35 pm
QMS Medical Allied Services Completes 100% Acquisition of Saarathi Healthcare QMS Medical Allied Services Ltd (QMS MAS) has completed the 100% acquisition of Saarathi Healthcare Pvt Ltd by acquiring the remaining 24% equity stake (1,98,000 shares) for a cash consideration of ₹14.225 crore. QMS MAS previously acquired a 51% stake in Jun'24 and raised it to 76% in Oct'25. The buyout bolsters QMS MAS's integrated healthcare capabilities across patient screening, diagnostics, and disease management. Backed by organic expansion and strategic partnerships, QMS MAS targets surpassing ₹500 crore in revenue by FY29.
QMS Medical Allied Services Limited has informed the Exchange about Acquisition by additional stake of 24% in Saarathi Healthcare Private Limited, a Subsidiary of the Company. Pursuant to the said acquisition the Company now holds 100% in Saarathi Healthcare Private Limited
Others (Uncategorized) · 17 Sept 2026, 10:10 pm
QMS Medical Acquires Full Ownership of Saarathi Healthcare for Rs 14.23 Crore QMS Medical Allied Services acquired the remaining 24% stake (1,98,000 shares) in subsidiary Saarathi Healthcare Private Limited for a cash consideration of Rs 14.23 crore, making it a wholly owned subsidiary. The acquisition aims to expand QMS's addressable market in value-added healthcare services. Saarathi Healthcare, which provides disease management, early diagnosis, screening, and awareness programs, reported an annual turnover of Rs 18.45 crore for FY26, up from Rs 16.29 crore in FY25 and Rs 13.33 crore in FY24.
QMS Medical Allied Services Limited has informed the Exchange about General Updates under Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
Others (Uncategorized) · 08 Sept 2026, 1:04 am
QMS Medical Allied Services Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 23-Sep-2026.
Dividend · 08 Sept 2026, 12:38 am
QMS Medical Allied Services Announces Record Date and Book Closure for AGM and Dividend QMS Medical Allied Services Ltd. has fixed 23rd Sep'26 as the record date for determining shareholder eligibility for its 9th AGM and dividend payout. The Register of Members and Share Transfer Books will remain closed from 24th Sep'26 to 30th Sep'26. The AGM is scheduled for 30th Sep'26. If approved by members, the dividend will be disbursed between 5th Oct'26 and 30th Oct'26, subject to applicable tax deductions at source.
QMS Medical Allied Services Limited has informed the Exchange regarding 'Annual Report '.
Annual Report · 08 Sept 2026, 12:31 am
QMS Medical Allied Services Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 08 Sept 2026, 12:10 am
QMS Medical Allied Services Limited has informed the Exchange regarding Appointment of Pranav Manhar Badheka as Non- Executive Independent Director of the company w.e.f. September 03, 2026.
Change in Management · 04 Sept 2026, 2:34 am
QMS Medical Allied Services Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.
Outcome · 04 Sept 2026, 2:27 am
QMS Medical Allied Services Limited has informed the Exchange regarding a press release dated August 27, 2026, titled "QMS Medical Allied Services signs a five-year agreement with HEINE Optotechnik, a global primary diagnostic instruments player, for exclusive marketing and distribution rights in India.".
Press Release · 27 Aug 2026, 4:58 pm
QMS Medical Signs Exclusive 5-Year Distribution Deal with Germany's HEINE QMS Medical Allied Services (QMSMEDI) signed a five-year exclusive marketing and distribution agreement with Germany-based HEINE Optotechnik, effective 1st Jan'27. QMS will be the sole distributor for HEINE's primary diagnostic instruments in India. HEINE's Indian revenue was ~€2.6M (~₹30 crore) in 2026, which QMS expects to grow to ₹70 crore by 2031 under the partnership. This deal is central to QMS's product expansion strategy and supports its ambitious target of surpassing ₹500 crore in revenue by FY29.
QMS Medical Allied Services Limited has informed the Exchange about Transcript
Transcript · 21 Aug 2026, 9:51 pm
QMS Medical Q1 FY27: Strong Growth Led by Services and Margin Expansion QMS Medical reported strong Q1 FY27 results with consolidated revenue at INR56.9 crores, up 22% YoY, and PAT at INR4 crores, up 25% YoY. EBITDA grew faster at 27% YoY to INR8.3 crores, with margins expanding to 14.6% from 14.1% YoY, driven by a higher contribution from the services segment. The PSP business generated INR17.6 crores. Management is progressing to acquire the remaining 24% stake in Saarathi Healthcare by Q2 FY27 end and is guiding for INR90-100 crores in service revenue for FY27.
QMS Medical Allied Services Limited has informed the Exchange about Achievement of Gold Certification in Cybersecurity Assessment by QMS Medical Allied Services Ltd
Others (Uncategorized) · 19 Aug 2026, 8:51 pm
QMS Medical Achieves Gold Cybersecurity Certification QMS Medical Allied Services (QMSMEDI) has received a "Gold" cybersecurity certification from CyberVadis, scoring 918/1000 and placing it in the "Mature" category. This independent assessment is a key pre-qualification for healthcare and pharma clients, enhancing client trust and competitive positioning. The certification, valid until 17 Aug'27, validates the company's robust data protection and risk management framework, mitigating financial and reputational risks from data breaches. This achievement is a positive governance signal to investors, underlining management's commitment to enterprise risk management.
QMS Medical Allied Services Limited has informed the Exchange about Link of Recording
Audio / Video · 17 Aug 2026, 11:44 pm
QMSMEDI: Audio Recording of Q1 FY27 Earnings Call Published QMS Medical Allied Services (QMSMEDI) has released the audio recording of its earnings call for the quarter ended Jun 30, '26. The call was held on Mon, Aug 17, '26, following the board's approval of the financial results on Fri, Aug 14, '26. The recording is now available on the company's website for investors and analysts.
QMS Medical Allied Services Limited has informed the Exchange about Investor Presentation
Investor Presentation · 17 Aug 2026, 6:20 pm
QMS Medical Allied Services: Strong Q1FY27 Driven by Robust YoY and QoQ Growth QMS Medical reported strong Q1FY27 results, with consolidated revenue up 22% YoY to Rs. 56.9 crore and PAT rising 25% YoY to Rs. 4.0 crore. The performance was driven by a significant 41% QoQ jump in EBITDA to Rs. 8.3 crore, expanding the EBITDA margin to 14.6%. The Services segment's revenue contribution grew to 41% from 24% YoY, highlighting its increasing importance. The company also announced plans to acquire the remaining stake in Saarathi Healthcare by the end of Q2FY27 to bolster its patient support programs.
QMS Medical Allied Services Limited has informed the Exchange about Investor Presentation
Investor Presentation · 17 Aug 2026, 4:47 pm
QMS Medical Allied Services Limited has informed the Exchange about Schedule of meet
Intimation · 17 Aug 2026, 12:00 pm
QMS Medical Allied Services: Q1 FY27 Earnings Call Details QMS Medical Allied Services (QMSMEDI) has scheduled its Q1 FY27 earnings conference call for Mon, 17th Aug'26, at 12:00 PM IST. The call will discuss financial results for the quarter ending 30th Jun'26. This announcement corrects a previous intimation from 12th Aug'26, which contained technical errors in the provided link. Management representatives will include Chairman & MD Mr. Mahesh Makhija and Director Compliance Mr. Mohit Tamhankar. Dial-in details have been provided for domestic and international participants.
QMS Medical Allied Services Limited has informed the Exchange about Schedule of meet
Intimation · 14 Aug 2026, 11:32 pm
QMS Medical Allied Services Schedules In-Person Investor Meeting QMS Medical Allied Services (QMSMEDI) will hold a one-on-one, in-person meeting with Ashika Investment Managers AIF on 19 Aug'26. As per the SEBI Regulation 30 filing, discussions will be limited to publicly available information, with no unpublished price-sensitive information (UPSI) intended to be shared. The schedule is subject to change.